The company's business model is viewed as being under threat from preventative healthcare models like HIMS, which could reduce the future number of patients needing dialysis by preventing chronic diseases like diabetes.

Mentioned as a large dialysis organization that is expected to ramp up adoption of CoreMedix's DefenCath product, driving growth for CRMD.